Qian Han, Xin-Yu Chen, Chao Liu*, Zhu-Xin Dong*, Ligand-Engineered Cu13 Nanoclusters Direct Distinct Programmed Cell Death Pathways for Tumor-Selective Therapy, 2025, Submitted.